Animal models of breast and prostate cancer “Advances in targeting cancer pathways” by Cinbo delegates MEDITERRANEAN SCHOOL OF ONCOLOGY 08 April 2016,

Slides:



Advertisements
Similar presentations
Case 20 Thomas J. Giordano, M.D., Ph.D.. History A 54-year old man with a past medical history of goiter for approximately 4 years was followed by ultrasound.
Advertisements

Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
Tumor Markers Lecture one By Dr. Reem Sallam. Objectives  To briefly introduce cancers, their incidence, some common terms, and staging system.  To.
Ancha Baranova George Mason University, Fairfax, VA
Reported by R5 李霖昆 Supervised by 楊慕華 大夫 Genomics-Driven Oncology: Framework for an Emerging Paradigm Review article Journal of Clinical Oncology 31, 15,
What is Li-Fraumeni syndrome?
MiRNA-drug resistance mechanisms Summary Hypothesis: The interplay between miRNAs, signaling pathways and epigenetic and genetic alterations are responsible.
Robert Farley University of Rhode Island Department of Biomedical Engineering.
Tumor Markers Lecture one By Dr. Waheed Al-Harizi.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Title, in bold style Subtitle, in regular Max 3 lines of text totally NB! The graphic outside the slide will not show in “Slide Show” or on print WntResearch.
Clinical Perspective. Screening/Prevention Who is at risk for what type Decision to Intervene: Risk Assessment normal Evidence of Disease Disability Death.
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
Studying angiosarcoma in dogs
Genomics Lecture 7 By Ms. Shumaila Azam. Tumor Tumor – abnormal proliferation of cells that results from uncontrolled, abnormal cell division A tumor.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
Presented by Karen Xu. Introduction Cancer is commonly referred to as the “disease of the genes” Cancer may be favored by genetic predisposition, but.
Understanding and Treating Triple-Negative Breast Cancer Elshami M. Elamin, MD Medical Oncologist Central Care Cancer Center Wichita,
Understanding and Optimizing Treatment of Triple Negative Breast Cancer Edith Peterson Mitchell, MD, FACP Clinical Professor of Medicine and Medical Oncology.
Genetic and Molecular Epidemiology
Eleni Galani Medical Oncologist
Genetic Alterations of TP53 Gene in Brain Astrocytic Tumours Methodology Θ Eighty-three brain tumor biopsies were collected and used in this study. Thirty.
Stem Cells In Clinical Practice: STELLA Experience Manolo D’Arcangelo Department of Oncology Ospedale Civile di Livorno.
Diseases of the Pancreas November 19, 2007 NCDD Meeting Chair: Jane Holt Vice Chair: P. Jay Pasricha, MD.
Dr. Ziad W Jaradat Cancer Stem Cells. Recently biologically distinct and relatively rare populations of tumor-initiating cells have been identified in.
MiR-19b/20a/92a regulates the self- renewal and proliferation of gastric cancer stem cells Journal of Cell Science (IF=5.325) 报告人:黄美玲
LUNG ADENOCARCINOMAS. CLINICOPATHOLOGICAL STUDY WITH RESPECT TO THE UPCOMING NEW CLASSIFICATION AND EGFR-KRAS MUTATION ANALYSIS IMPLICATIONS. First author:
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) in Non-Small Cell Lung Cancer (NSCLC) Victor.
FINDING THE DISEASE GENES PROGRESS AND PROBLEMS THE HUMAN GENOME MAPPING PROJECT SEEKS TO READ THE FULL SEQUENCE OF THE HUMAN GENOME 3 Billion bases.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Marco Magistri , Journal Club. A non-coding RNA (ncRNA) is any RNA molecule that is not translated into a protein “Structural genes encode proteins.
Apostolos Zaravinos and Constantinos C Deltas Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological.
SP Cancer Metastasis Summary Hypothesis: We hypothesize that miRNAs regulate breast cancer cell invasiveness and metastasis by synergistically targeting.
OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.
Gene Expression Signatures for Prognosis in NSCLC, Coupled with Signatures of Oncogenic Pathway Deregulation, Provide a Novel Approach for Selection of.
Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets.
Potential therapeutic target & predictive biomarker Oncogenic IGFBP2 Sonya Song ( 宋韦 ) Beijing Shijitan Hospital Department of Oncology The Capital Medical.
OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best.
Decoding the Network Footprint of Diseases With increasing availability of data, there is significant activity directed towards correlating genomic, proteomic,
Prognostic and Predictive Factors: Current Evidence for Individualized Therapy Predictive Molecular Markers: Hormone Receptor Status Presented by Kathleen.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Establishment and verification of miRNAs expression molecules for breast cancer and its distant metastasis Yanhong Gao Associate Professor Department of.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
INTERPRETING GENETIC MUTATIONAL DATA FOR CLINICAL ONCOLOGY Ben Ho Park, M.D., Ph.D. Associate Professor of Oncology Johns Hopkins University May 2014.
Samuel Aparicio, B.M., B.Ch., Ph.D., and Carlos Caldas, M.D.
NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.
Basal Type Breast Adenocarcinoma Eva Desmond DT204/2 C
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Prepared by : Dr. Nehad J. Ahmed. Cancer is a disease that results from abnormal growth and differentiation of tissues. Tumor or neoplasm - A mass of.
AR-V7 Splice Variant in Prostate Cancer : Taking Centre Stage
The National Cancer Research Network is part of the National Institute for Health Research CANCER GENETIC TRIALS Leicestershire, Northamptonshire and Rutland.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Precision Medicine: The Potential for Identifying Personalized Therapies for Patients with Gastro-Esophageal Cancer.
NISCHR Academic Health Science Collaboration Launch
GENETIC BIOMARKERS.
Pharmacogenomics: towards personalized medicine
MCW Regional Cancer Therapy Program
OMICS Journals are welcoming Submissions
The Dog as a Model of Human Cancer
Transcriptional Signature of Histone Deacetylases in Breast cancer
Jean-Charles Nault, Peter R. Galle, Jens U. Marquardt 
Handling and Evaluation of Breast Cancer Biopsy
PROSTATE CANCER CIRCULATING BIOMARKER CONSENSUS STATEMENT QUESTIONS
Cancer is a Challenge Cancer is common in humans – a public health problem ~1 of every 3 women will develop cancer ~1 of every 2 men will develop cancer.
Cancer Stem Cells: Current Status and Evolving Complexities
role of comparative oncology in translational research
Stat4Onco Annual Symposium Zhenming Shun April 27, 2019
Presentation transcript:

Animal models of breast and prostate cancer “Advances in targeting cancer pathways” by Cinbo delegates MEDITERRANEAN SCHOOL OF ONCOLOGY 08 April 2016, Rome, Italy

In Vivo Model Systems In Cancer Research: Laboratory rodent models  xenograft and genetically-engineered mouse models Spontaneous animal models  companion animals (pet dogs and cats) naturally developing cancer

Comparative Oncology discipline that integrates the study of naturally occurring cancers in veterinary patients into studies of human cancer biology and therapy Main objectives of comparative oncology: - Study of cancer pathogenesis  cancer-associated genes and proteins - Understanding of environmental risk factors for cancer - Examination of genetic/familial determinants for cancer predispositions - Development of new treatment options for the management of cancer in both humans and animals

Advantages of spontaneous models for translational research:  naturally-occurring, with individual-to-individual heterogeneity within and across cancer types  growth in immunocompetent organisms within the tumor microenvironment  shorter natural history  sharing of the same environment with humans  highly comparable risk factors

Spontaneous cancers of pets share tumor biology /genetics and clinical behaviour with human cancers Frequently, similar tumor histology and response rates to conventional chemotherapy Sufficient prevalence for biological studies and clinical trials Feasibility of multi-modality protocols Rapid progression and early metastatic failure  rapid completion of clinical trials In addition:

Spontaneously occurring canine mammary tumours (CMTs) are the most common neoplasm in the intact adult female dog Malignant tumors account for up to 50% of cases Strong clinical (e.g. hormonal dependence, age of onset, histological features, prognostic factors, course of the disease) and molecular similarities to human BC The Canine Spontaneous Model for Breast Cancer (BC) Research

Canine mammary carcinomas (CMCs) harbor extensive genetic alterations, like human BC Common up-regulation of prominent oncogenic pathways and related genes (e.g. PI3K/AKT, KRAS, MAPK, Wnt / β -catenin, BRCA2, ESR1, P-cadherin) Down-regulation of representative tumor suppressive pathways (e.g. p53, p16/INK4A, PTEN, E-cadherin)  Valid model for basic and translational BC research Comprehensive expression profiles of miRNAs in CMCs (e.g. miR-21)  altered regulation strongly correlated with those found in human BC

Suitable model for hormone-independent human BC due to the frequent lack of oestrogen dependency Most of feline mammary tumours are malignant Associated with aggressive clinical course and rapid metastasization The Feline Spontaneous Model for Breast Cancer (BC) Research

So far, studies mainly focused on the canine model Availability of a high-quality draft genome sequence, together with a dense map of single nucleotide polymorphisms: High level of sequence conservation between canine and human genomes  Possibility of extensive genomic analyses Several anatomic and physiologic similarities with humans Frequently comparable drug metabolism with humans

Research topics for the canine BC model Triple-negative (TN) subtype has been identified among CMCs Distinct clinicopathological features related to unfavourable prognosis Basal-like phenotype for the majority of TN CMCs

 Possibility to investigate molecular prognostic markers and to identify targetable driver mutations / signaling pathways in TN CMCs

Research topics for the canine BC model Inflammatory mammary carcinoma (IMC): the most aggressive mammary neoplasia affecting female dogs Considerable epidemiologic, clinical and histopathological similarities shared by human inflammatory breast cancer (IBC) and canine IMC  Basic and translational studies are needed to understand IBC and IMC disease biology and identify specific biomarkers

Research topics for the canine BC model  Canine IMC has been proposed as the best spontaneous animal model for the study of human IBC 2015 Studies on IBC are limited by the few available IBC cell lines, experimental models, and paucity of patient samples

- Studies on primary CSC cultures derived from human postsurgical BC samples are limited (only small amounts of fresh tissue are obtainable from individual human BCs) CSCs has been isolated and characterized from primary canine and feline mammary carcinomas Comparative oncology is also acquiring a relevant role in cancer research on cancer stem cells (CSCs): - Most studies concerning CSCs rely on established cancer cell lines

 Relevant source of biological material necessary to isolate mammary CSCs  Valuable translational models for human BC and to assay drug targeting to tumor-initiating cells Primary canine and feline mammary carcinomas represent:

The dog is the only species other than man to spontaneously develop PC at a significant incidence The Canine Spontaneous Model for Prostate Cancer (PC) Research

Unique features of canine PC  usually arise in an androgen-independent manner, with increased risk in dogs castrated early in life  skeletal metastases are osteoblastic or mixed osteoblastic/osteolytic in nature, similar to men The Canine Spontaneous Model for Prostate Cancer (PC) Research

Common occurrence of bone metastases and androgen-independent disease in dogs with PC  good model for studying advanced, hormone-refractory PC in humans Valid model for investigating prostate-specific effects on bone The larger size of dogs makes them helpful to investigate new molecular imaging tools that cannot be performed readily on mice

The value of spontaneous cancers in understanding and managing cancer has been evident to veterinary oncologists and cancer researchers for many years but … … the awareness of naturally occurring cancer models is still relatively limited in the cancer research community Conclusive remarks:

Future challenges for improving comparative oncology studies: broader awareness of the usefulness of naturally occurring cancer models needs that comparative oncology answers very specific questions increased collaboration and interaction between veterinary / comparative oncologists and the cancer research community centralized resources for the establishment of comparative oncology programs

Thank you for your attention! ”Man's best friend in more ways than one”…